Madrigal Pharmaceuticals Inc

YDO1.SG·Stuttgart
Compare
325.20−49.90 (−13.30%)today
At close: Nov 4, 5:18 PM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close375.10
Open355.20
Day range320.30355.70
52-week range320.30519.60
Off day high−8.57%
Off 52-week high−37.41%
Volume48.00
Avg. volume (3M)3.00
Market cap—
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding—
Short interest—
Earnings dateNov 3, 2026
Analyst target—
Profit margin—

Related companies

Compare ›

The stocks whose daily moves over the past year went most closely with Madrigal Pharmaceuticals's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Madrigal Pharmaceuticals, Inc.YDO1.F · Correlation 0.67 8.21B 353.60 +0.06%

What visitors to Madrigal Pharmaceuticals's page also look at.

Company Mkt cap Price Today
Madrigal Pharmaceuticals Inc. RYDO1.F 8.21B 353.60 +0.06%
Edel SE & Co. KGaAEDL.MU — 4.6600 0.00%
Edel SE & Co. KGaAEDL.DU — 4.6200 +0.43%
Los Andes Copper Ltd.L41A.MU — 8.15 0.00%
PATO_PATO CHEMICAL INDUSTRYPATO-R.BK — 6.10 0.00%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All YDO1.SG news ›
Madrigal Pharmaceuticals··2 outlets

Madrigal Pharmaceuticals Reports Third-Quarter 2026 Financial Results and Provides Corporate Updates

Third Quarter 2026 and Recent Corporate Updates As disease awareness improves and disease prevalence increases, the number of diagnosed patients with F2 to F4c MASH is growing. Madrigal may use its website to comply with its disclosure…

MDGL
More from 1 other outlet
Markets Daily··2 outletsPositive

OSR (NASDAQ:OSRH) versus Madrigal Pharmaceuticals (NASDAQ:MDGL) Head-To-Head Survey

Posted by Mitch Edgeman on Nov 2nd, 2026 Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) and OSR (NASDAQ:OSRH – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two businesses…

MDGLMIRMMRKJNJ
More from 1 other outlet

From the 4Search news index, newest first.

In the news

22mentions in 30 days
22with it in the headline
Positivesentiment

Mentioned with

Macrogenics10Eli Lilly and Company5Johnson & Johnson5Merck & Co., Inc.5Pfizer5Sanofi5Emergent Biosolutions4Fortress Biotech4

People in the coverage

Marketbeat13Sarita Garza13Mitch Edgeman11Danessa Lincoln9Madrigal8Michael Walen8

Themes

Healthcare14Comparison10Earnings10Review10Stock Analysis9Stock Comparison9Valuation9Analyst Recommendations8

Most coverage from

  1. themarketsdaily.com7
  2. globenewswire.com2
  3. ir.madrigalpharma.com2
  4. seekingalpha.com2
  5. blackchronicle.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 22 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance